Michael Narachi

Insider Reports History

Entity
Individual
Location
C/O Orexigen Therapeutics, Inc., 3344 N Torrey Pines Ct, #200, La Jolla, CA
Signature
/s/ Karah Parschauer, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Narachi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. Director Common Stock 27K $1.21M $45.00 Jun 18, 2024 Direct
Ultragenyx Pharmaceutical Inc. Director Stock Option (Right to Buy) 9.9K Jun 18, 2024 Direct

Insider Reports Filed by Michael Narachi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RARE Ultragenyx Pharmaceutical Inc. Jun 18, 2024 2 $0 4 Jun 20, 2024 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 7, 2023 2 $0 4 Jun 9, 2023 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 24, 2022 2 $0 4 Jun 28, 2022 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 24, 2021 2 $0 4 Jun 28, 2021 Director